A Phase I, Open-Label, Randomized, Crossover Trial in Healthy Adults to Compare the Oral Bioavailability of TMC278 From Three Concept Pediatric Formulations (Solution, Suspension, Granules) With That From the Adult Phase III Tablet Formulation.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2010
At a glance
- Drugs Rilpivirine (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 23 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 23 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2009 Actual start date (Jan 2009) added as reported by ClinicalTrials.gov.